Evidence from a small-scale clinical trial suggests that a variation of the advanced blood cancer immunotherapy known as CAR-T could be adapted to treat myasthenia gravis, an autoimmune disorder of ...

Former tennis star Monica Seles recently revealed she is living with the rare disease myasthenia gravis, which affects 12 in 100,000 people globally. Seles explained her first symptoms appeared ...

Myasthenia gravis patients show significantly reduced QOL, even with low disease activity, compared to the general population, as indicated by EQ-5D scores. Disease activity impacts all EQ-5D ...

Decisions about thymectomy in myasthenia gravis (MG) depend on several variables. Two important categories are whether the patient's thymus gland has thymoma or not and what type of autoantibodies, if ...

SAVANNAH, Ga. — Should patients with myasthenia gravis (MG) continue to undergo the traditional therapy of immunosuppression with drugs like corticosteroids and nonsteroidal agents? Or is it time to ...

Myasthenia gravis usually does not shorten life expectancy, but severe muscle weakness that affects breathing can be life threatening. Myasthenia gravis symptoms may begin suddenly and often progress ...

Three drugs that inhibit the immunoglobulin G (IgG) neonatal fragment crystallizable receptor (FcRn) were approved to treat generalized myasthenia gravis (MG) in recent years: efgartigimod (Vyvgart), ...

Investigators evaluated the utility of the MG Symptoms Patient-Reported Outcome (PRO) within the armamentarium of instruments that currently evaluate myasthenia gravis (MG) severity. The ...

UCB, a global biopharmaceutical company, today announced the recipients of its annual UCB Myasthenia Gravis Scholarship,™ ...